Other
Preferred Stock, Shares Outstanding
Bristol-Myers Squibb Preferred Stock, Shares Outstanding decreased by 12.5% to 2.5K in Q4 2025 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Preferred Stock, Shares Outstanding shows a downward trend with a -10.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2025Feb 11, 2026
How to read this metric
An increase indicates the issuance of new preferred equity, while a decrease signals share repurchases or conversions into common stock.
Detailed definition
This metric quantifies the total number of preferred stock shares currently held by all shareholders, excluding treasury...
Peer comparison
Most large-cap pharmaceutical companies have simplified capital structures, so this is often zero or very low compared to common share counts.
Metric ID:
other_preferred_stock_shares_outstandingHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | 3K | 2.9K | 2.5K |
| QoQ Change | — | -2.9% | -12.5% |
| YoY Change | — | -2.9% | -12.5% |
Range2.5K – 3K
Avg YoY Growth-7.7%
Median YoY Growth-7.7%
Current Streak2+ quarters decline
Preferred Stock, Shares Outstanding at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's preferred stock, shares outstanding?
- Bristol-Myers Squibb (BMY) reported preferred stock, shares outstanding of 2.5K in Q4 2025.
- What is the long-term trend for Bristol-Myers Squibb's preferred stock, shares outstanding?
- Over 3 years (2020 to 2025), Bristol-Myers Squibb's preferred stock, shares outstanding has grown at a -10.4% compound annual growth rate (CAGR), from 3.5K to 2.5K.
- What does preferred stock, shares outstanding mean?
- The total number of preferred stock shares currently held by investors.